UK Markets close in 43 mins

Adverum Biotechnologies, Inc. (0HA3.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.8020+0.0519 (+6.92%)
As of 04:32PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.78
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 30.0000
52-week low 30.0000
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 562.87M
Implied shares outstanding 6N/A
Float 885.39M
% held by insiders 13.67%
% held by institutions 163.21%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-22.92%
Return on equity (ttm)-56.36%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-81.68M
EBITDA -144.79M
Net income avi to common (ttm)-156.21M
Diluted EPS (ttm)-1.3800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)203.26M
Total cash per share (mrq)2.04
Total debt (mrq)105.7M
Total debt/equity (mrq)50.74
Current ratio (mrq)7.45
Book value per share (mrq)4.45

Cash flow statement

Operating cash flow (ttm)-115.43M
Levered free cash flow (ttm)-83.51M